Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Lendify in connection with a capital raising
Mandate

Vinge has advised Lendify in connection with a capital raising

January 08, 2018

Lendify, a Swedish platform for the granting and brokering of consumer credits, has carried out a capital raising by way of a share issue in the amount of SEK 111.5 million (with the issue being based on a pre-money valuation of Lendify amounting to SEK 650 million).

The capital is intended to be used for funding technical development and as equity in forthcoming issuance of corporate bonds.

Vinge acted for Lendify AB, and the team consisted of Jonas Johansson as partner in charge with associates Louise Nordkvist and Anna Thoms.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026